open-label BE trials maintain blindness [Study Per­for­mance]

posted by ElMaestro  – Denmark, 2023-10-14 19:39 (636 d 07:55 ago) – Posting: # 23755
Views: 5,093

Hi kimhaung,

❝ How do open-label BE trials maintain blindness until the database is locked?


I had a small coughing fit reading this line :-)

Can I ask:
  1. Who do you want to keep blind and why? Monitor, PI, bioanalytical staff, QA, sponsor, PK staff, statistics staff, pharmacy staff, clinical staff etc?
  2. Are the people who create the rand. code also the people who do NCA? is it the same people who do stats?
  3. Who has access to the rand. code? I do not mean who should have access.
  4. Do some of the staff with access to the rand. code also undertake other functions by any chance?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,434 posts in 4,931 threads, 1,674 registered users;
71 visitors (0 registered, 71 guests [including 30 identified bots]).
Forum time: 03:35 CEST (Europe/Vienna)

For every expert there is an equal and opposite expert.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5